Overview
Interrupted aortic arch (IAA), also known as aortic arch interruption, is a rare congenital heart defect in which there is a complete discontinuity (gap) between two segments of the aortic arch. This means that blood cannot flow normally from the heart to the lower body through the aorta. The condition is classified into three types based on the location of the interruption: Type A (interruption distal to the left subclavian artery), Type B (interruption between the left common carotid and left subclavian arteries, the most common form), and Type C (interruption between the innominate and left common carotid arteries, the rarest form). IAA is frequently associated with other cardiac anomalies, most notably a ventricular septal defect (VSD) and patent ductus arteriosus (PDA). The PDA is critical for survival in the neonatal period, as it provides the only pathway for blood to reach the lower body. Newborns with interrupted aortic arch typically present within the first days of life with signs of cardiovascular collapse as the ductus arteriosus begins to close. Symptoms include severe respiratory distress, poor feeding, weak or absent pulses in the lower extremities, metabolic acidosis, and signs of shock. Without treatment, the condition is fatal. Type B interruption is strongly associated with 22q11.2 deletion syndrome (DiGeorge syndrome), which may include additional features such as immune deficiency, hypocalcemia, and characteristic facial features. Immediate management involves administration of prostaglandin E1 (PGE1) to maintain ductal patency and stabilize the infant. Definitive treatment requires open-heart surgery, typically performed in the neonatal period, to reconstruct the aortic arch and repair associated cardiac defects such as VSD. Surgical outcomes have improved significantly over recent decades, and many patients survive into adulthood, though long-term follow-up is essential to monitor for complications such as re-coarctation, left ventricular outflow tract obstruction, and aortic valve abnormalities. Genetic counseling is recommended, particularly when 22q11.2 deletion is identified.
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Aortic arch interruption.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Aortic arch interruption at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Aortic arch interruption.
Community
No community posts yet. Be the first to share your experience with Aortic arch interruption.
Start the conversation →Latest news about Aortic arch interruption
No recent news articles for Aortic arch interruption.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Aortic arch interruption
What is Aortic arch interruption?
Interrupted aortic arch (IAA), also known as aortic arch interruption, is a rare congenital heart defect in which there is a complete discontinuity (gap) between two segments of the aortic arch. This means that blood cannot flow normally from the heart to the lower body through the aorta. The condition is classified into three types based on the location of the interruption: Type A (interruption distal to the left subclavian artery), Type B (interruption between the left common carotid and left subclavian arteries, the most common form), and Type C (interruption between the innominate and left
At what age does Aortic arch interruption typically begin?
Typical onset of Aortic arch interruption is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Aortic arch interruption?
3 specialists and care centers treating Aortic arch interruption are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.